Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Adage Capital Partners GP L.L.C.

Adage Capital Partners GP L.L.C. reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 411,626 shares of the medical equipment provider's stock after selling 8,958 shares during the period. Adage Capital Partners GP L.L.C. owned 0.12% of Intuitive Surgical worth $214,852,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Atala Financial Inc purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $25,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at $28,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical during the 4th quarter worth about $28,000. Finally, Summit Securities Group LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at about $30,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $478.74 on Wednesday. The company has a 50-day simple moving average of $517.55 and a 200-day simple moving average of $532.24. The company has a market cap of $170.52 billion, a PE ratio of 74.69, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12 month low of $367.39 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same period in the previous year, the company earned $1.50 EPS. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In related news, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company's stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.70% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Evercore ISI increased their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a "neutral" rating and a $550.00 target price for the company. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Finally, BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $611.81.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.